title: Imiquimod treatment of lentigo maligna: an open-label study of 34 primary lesions in 32 patients.
authors.forename: Urs V
authors.initials: UV
authors.lastname: Buettiker
authors.forename: Nikhil Y
authors.initials: NY
authors.lastname: Yawalkar
authors.forename: Lasse R
authors.initials: LR
authors.lastname: Braathen
authors.forename: Robert E
authors.initials: RE
authors.lastname: Hunger
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use*; D000279:Administration, Cutaneous; D000368:Aged; D000634:Aminoquinolines / Q000008:administration & dosage / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005145:Face / Q000473:pathology; D005260:Female; D006801:Humans; D018327:Hutchinson's Melanotic Freckle / Q000188:drug therapy* / Q000473:pathology; D000077271:Imiquimod; D008297:Male; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D000970:Antineoplastic Agents; D000077271:Imiquimod